Milestone Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Milestone Pharmaceuticals

11/05/2023 17:41

* Milestone Pharmaceuticals Inc  MIST.OQ  reported a
quarterly
adjusted loss of 35 cents​​ per share for the quarter ended in
March. The mean expectation of five analysts for the quarter was
for a loss of 40 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Milestone Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 35 cents​.
    * The mean earnings estimate of analysts had fallen by
about 2.1%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * Milestone Pharmaceuticals Inc shares had fallen by 1.0%
this
quarter and lost 1.5% so far this year.
    * The company reported a quarterly loss of $14.95 million.
    * Wall Street's median 12-month price target for Milestone
Pharmaceuticals Inc is $13.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 04:41 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.40          -0.35          Beat
 Dec. 31 2022      -0.33          -0.31          Beat
 Sep. 30 2022      -0.41          -0.34          Beat
 Jun. 30 2022      -0.36          -0.39          Missed